A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment.
<h4>Background</h4>Signs of senescence and the late stages of differentiation associated with the more severe forms of Chagas disease have been described in the Trypanosoma cruzi antigen-specific CD4+ T-cell population. However, the mechanisms involved in these functions are not fully kn...
Saved in:
Main Authors: | Elena Pérez-Antón (Author), Adriana Egui (Author), M Carmen Thomas (Author), Bartolomé Carrilero (Author), Marina Simón (Author), Miguel Ángel López-Ruz (Author), Manuel Segovia (Author), Manuel Carlos López (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
by: Elena Pérez-Antón, et al.
Published: (2018) -
Access to benznidazole for Chagas disease in the United States-Cautious optimism?
by: Jonathan D Alpern, et al.
Published: (2017) -
Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
by: Miriam Rolon, et al.
Published: (2022) -
Benznidazole-Loaded Polymeric Nanoparticles for Oral Chemotherapeutic Treatment of Chagas Disease
by: Lucas Resende Dutra Sousa, et al.
Published: (2024) -
Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.
by: Lívia de Figueiredo Diniz, et al.
Published: (2013)